– TCOYD & diaTribe Present –
20th ANNUAL DIABETES FORUM & RECEPTION
The Ideal Way to Liven Up Your ADA Experience–with Colleagues & Key Opinion Leaders!
• Expert Insights
• Professional Connections
• Dynamic Learning
• Open Bar
JUNE 7, 2026
6pm CDT
Hilton New Orleans Riverside
– 20th ANNUAL DIABETES FORUM & RECEPTION –
The Ideal Way to Liven Up Your ADA Experience–with Colleagues & Key Opinion Leaders!
Expert Insights • Professional Connections • Dynamic Learning • Open Bar
JUNE 7, 2026 | 6pm CDT | Hilton New Orleans Riverside
New Format, More Fun: Diabetes Jeopardy! Returns to Enhance the 86th ADA Scientific Sessions
After 20 years of bringing diabetes professionals together, we’re celebrating with the format you loved in 2025—now in the heart of New Orleans!
This year, for those of you who planned on heading home Monday, we’ve moved the event to Sunday so it’s easier for more people to attend while the ADA Scientific Sessions are still in full swing!
As we all know – ADA Scientific Sessions are intense, three days of back-to-back presentations, clinical data, poster sessions, and exhibit halls! By Sunday evening, your brain is ALMOST full—it’s time to let loose, have some fun, and enjoy the show!
Early Bird Pricing Ends March 31st!
ONLINE REGISTRATION NOW CLOSED–Tickets Available Onsite!
2026 FORUM HOSTS
Dr. Edelman is a professor of medicine in endocrinology at UC San Diego and the VA Healthcare System. Living with type 1 diabetes himself, he has authored over 200 publications and five books, and is a nationally recognized educator and advocate. He’s received multiple honors, including ADA’s Diabetes Educator of the Year, AACE’s Distinction in Endocrinology, and was named among the top 1% of U.S. endocrinologists by U.S. News & World Report. In 1995, he founded the nonprofit Taking Control of Your Diabetes (TCOYD) to empower people living with diabetes.
Dr. Pettus is an endocrinologist and Assistant Professor of Medicine at UC San Diego. Diagnosed with type 1 diabetes at age 15, he has dedicated his career to advancing care for others with T1D. His research focuses on innovative therapies, from disease-modifying medications and islet cell transplants to artificial pancreas technology. As a physician, researcher, and person living with T1D, he brings unique insight and passion to the TCOYD education team.
CONTESTANTS/PANELISTS
Hoag Medical Group, Newport Beach, California
University of Toronto, Canada
University of Leicester, UK
Duke University, North Carolina
ONLINE REGISTRATION NOW CLOSED–Tickets Available Onsite!
Early Bird Pricing Ends March 31st!
The most exciting categories of 2026 Diabetes Jeopardy at the ADA will be announced soon!
Play alongside leading experts, watch as their knowledge is tested, share in insights about the latest ADA breakthroughs, and engage in friendly competition:
- Hear perspectives on the most significant ADA announcements directly from key opinion leaders—delivered in a way that actually sticks
- Connect with colleagues and diabetes thought leaders in a relaxed atmosphere with an open bar and appetizers (because the best conversations happen over drinks, not business cards)
- Laugh, unwind, and celebrate the incredible amount of new data coming out of this weekend!
Sunday, June 7, 2026 | The Final Night of the ADA Scientific Sessions
6:00 PM – Reception and Networking with Open Bar
7:00 PM – Diabetes Jeopardy! Game Show with Leading Experts
8:30 PM – Coffee and Desserts
9:00 PM – Event Conclusion
Who Should Attend?
✓ Endocrinologists and diabetes specialists
✓ CDCES, nurses, and diabetes care teams
✓ Researchers and clinical trial investigators
✓ Industry professionals in diabetes care
✓ Anyone who wants to end their ADA experience on a high note
Early Bird Pricing Ends March 31st!
This one-of-a-kind educational event brings together the brightest minds in diabetes care, and we would love you to be a part of this exciting and fun experience.
That’s exactly why we created Diabetes Jeopardy!
Watch and play alongside the leading experts, test their knowledge, share insights about the latest ADA breakthroughs, and engage in friendly competition:
2025 Categories Include:
Diabetes Technology
- Hybrid Closed Loop Systems with AID (5 different ones)
- Updates in CGMs (Dexcom, Abbott and Eversense updates)
- Closed Loop dual hormonal systems (Insulin/Glucagon)
- Continuous Ketone Monitoring
Cardio-Renal-Hepatic Metabolic Syndromes
- Approaches to prevention
- Early diagnosis with laboratory tests:
– UA/CR, Fib 4, Cardiac Echo, BNP
- Effective treatment options:
– SGLT inhibitors, GLP1 RAs, Dual agonists, New medications (Resmetirom, Rezdiffra)
Obesity/GLP1/Dual and new triple agonists
- Ultra high dose GLP1s
- Update on FDA indications and the ever-growing benefits on:
– Heart, Kidney, Liver, Obstructive Sleep Apnea, Prediabetes
Type 1 Diabetes
- Define the 3 stages and the approaches using prevention in stages 1 and 2 (teplizumab or TZIELD)
- Preservation for early stage 3
- Replacement for later stage 3
- Stage 3 approved treatments such as:
– Afrezza (new data from INHALE 1 and 3), Toujeo, Tresiba
PLUS Exciting new data shared at the ADA and more!
2025 DIABETES FORUM IS SUPPORTED BY:
BEST IN CLASS
FIRST IN CLASS
SUSTAINING
